A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Freddy A. Jimenez net worth and biography

Freddy Jimenez Biography and Net Worth

SVP of Celldex Therapeutics

Mr. Jimenez is Senior Vice President and General Counsel of Celldex. Mr. Jimenez joined Celldex in 2016 as Vice President, Law and Compliance, serving as the Company’s chief counsel and compliance officer as well as providing executive leadership of information technology. Prior to joining Celldex, Mr. Jimenez spent 23 years at Johnson & Johnson (J&J) in various roles, including head of the pharmaceutical regulatory legal group for J&J where he coordinated legal strategy, deployment, and provided advice and counsel regarding regulatory, compliance, and fraud and abuse matters. Mr. Jimenez also worked in the Food & Drug Practice at the Washington DC-based law firm of Akin Gump Strauss Hauer & Feld LLP. He is on the Board of Directors and is General Counsel for the Food and Drug Law Institute and has authored numerous publications focused on regulatory law and compliance. Mr. Jimenez received his JD from the Rutgers School of Law – Newark and completed his undergraduate work at Brandeis University with a B.A. in Biology and Certificate in the Legal Studies Program.

What is Freddy A. Jimenez's net worth?: The estimated net worth of Freddy A. Jimenez is at least $16,705.50 as of August 11th, 2021. Mr. Jimenez owns 430 shares of Celldex Therapeutics stock worth more than $16,706 as of April 23rd. This net worth approximation does not reflect any other assets that Mr. Jimenez may own. Additionally, Mr. Jimenez receives an annual salary of $579,700.00 as SVP at Celldex Therapeutics. Learn More about Freddy A. Jimenez's net worth.
How old is Freddy A. Jimenez?: Mr. Jimenez is currently 55 years old. There are 8 older executives and no younger executives at Celldex Therapeutics. The oldest executive at Celldex Therapeutics is Prof. Joseph P. Schlessinger Ph.D., Co-Founder & Member of Scientific Advisory Board, who is 79 years old. Learn More on Freddy A. Jimenez's age.
What is Freddy A. Jimenez's salary?: As the SVP of Celldex Therapeutics, Inc., Mr. Jimenez earns $579,700.00 per year. There are 5 executives that earn more than Mr. Jimenez. The highest earning executive at Celldex Therapeutics is Mr. Anthony S. Marucci M.B.A., Founder, President, CEO & Director, who commands a salary of $1,140,000.00 per year. Learn More on Freddy A. Jimenez's salary.
How do I contact Freddy A. Jimenez?: The corporate mailing address for Mr. Jimenez and other Celldex Therapeutics executives is 53 FRONTAGE ROAD SUITE 220, HAMPTON NJ, 08827. Celldex Therapeutics can also be reached via phone at (908) 454-7120 and via email at [email protected]. Learn More on Freddy A. Jimenez's contact information.
Has Freddy A. Jimenez been buying or selling shares of Celldex Therapeutics?: Freddy A. Jimenez has not been actively trading shares of Celldex Therapeutics during the last ninety days. Most recently, on Wednesday, August 11th, Freddy A. Jimenez bought 430 shares of Celldex Therapeutics stock. The stock was acquired at an average cost of $46.28 per share, with a total value of $19,900.40. Following the completion of the transaction, the senior vice president now directly owns 430 shares of the company's stock, valued at $19,900.40. Learn More on Freddy A. Jimenez's trading history.
Who are Celldex Therapeutics' active insiders?: Celldex Therapeutics' insider roster includes Sarah Cavanaugh (SVP), Elizabeth Crowley (VP), Freddy Jimenez (SVP), Samuel Martin (CFO), Anthonly Marucci (President & CEO), and Diane Young (SVP). Learn More on Celldex Therapeutics' active insiders.

Freddy A. Jimenez Insider Trading History at Celldex Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2021	Buy	430	$46.28	$19,900.40	430

Freddy A. Jimenez Buying and Selling Activity at Celldex Therapeutics

Celldex Therapeutics Company Overview

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

Today's Range

Now: $38.85

$37.99

$39.40

50 Day Range

MA: $42.06

$35.27

$51.88

2 Week Range

Now: $38.85

$22.11

$53.18

Volume

552,455 shs

Average Volume

893,827 shs

Market Capitalization

$2.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad